A Japanese research team says it has developed a method to screen out iPS cells that are particularly good at differentiating into body cells.
The finding could help enhance the safety of regenerative therapy that uses these types of reprogrammed stem cells.Experts have learned that some iPS cells are adept at differentiating, while others are not and are prone to turning cancerous later on.
A research group from Kyoto and Kobe Universities compared the 2 types of cells.
They found that 3 particular genes were active in iPS cells that are not good at differentiating.
Source: NewsOnJapan
A research group from Kyoto and Kobe Universities compared the 2 types of cells.
They found that 3 particular genes were active in iPS cells that are not good at differentiating.
Source: NewsOnJapan
